| HDAC inhibitors in acute myeloid leukemia E San José-Enériz, N Gimenez-Camino, X Agirre, F Prosper Cancers 11 (11), 1794, 2019 | 159 | 2019 |
| Technological advances in three-dimensional skin tissue engineering R Cai, N Gimenez-Camino, M Xiao, S Bi, KA DiVito Reviews on Advanced Materials Science 62 (1), 20220289, 2023 | 15 | 2023 |
| Differentiation therapy with novel epigenetic inhibitors in acute myeloid leukemia E San Jose, N Gimenez-Camino, O Rabal, E Miranda, L Garate, F Garcia, ... Blood 134, 3762, 2019 | 1 | 2019 |
| Epigenetic-based differentiation therapy for Acute Myeloid Leukemia E San José-Enériz, N Gimenez-Camino, O Rabal, L Garate, E Miranda, ... Nature Communications 15 (1), 5570, 2024 | | 2024 |
| Novel epigenetic based differentiation therapy for Acute Myeloid Leukemia E San José-Enériz, N Gimenez-Camino, O Rabal, L Garate, E Miranda, ... | | 2023 |
| Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia N Giménez-Camino Servicio de Publicaciones. Universidad de Navarra., 2022 | | 2022 |
| SYNERGIC EFFECT OF NEW HDACS INHIBITORS WITH CHEMOTHERAPIC DRUGS IN ACUTE MYELOID LEUKEMIA GC Naroa, JE San Edurne, M Estibaliz, G Leire, PL Antonio, O Julen, ... HAEMATOLOGICA 106 (10), 89-90, 2021 | | 2021 |
| DIFFERENTIAL AND INNOVATIVE EPIGENETIC THERAPY FOR THE CURE OF ACUTE MYELOID LEUKAEMIA E San Jose-Eneriz, N Gimenez-Camino, O Rabal, E Miranda, L Garate, ... HAEMATOLOGICA 104, 242-242, 2019 | | 2019 |
| Iluntasunetik argirantz, genoma ez-kodetzailea kodetuz X Agirre, N Gimenez, A Amundarain Osagaiz: osasun-zientzien aldizkaria 3 (1), 2019 | | 2019 |
